2017
DOI: 10.11604/pamj.2017.27.189.9535
|View full text |Cite
|
Sign up to set email alerts
|

Le surpoids, l’obésité et le contrôle glycémique chez les diabétiques du centre de référence provincial de diabète (CRD), Kénitra, Maroc

Abstract: IntroductionLe diabète est définit comme un trouble de l'assimilation, de l'utilisation et du stockage des sucres apportés par l'alimentation, sa prise en charge est assurée par le suivi du surpoids et l'obésité et le contrôle glycémique régulier. L'objectif de ce travail était l'étude du surpoids, l'obésité et le contrôle glycémique chez 2227 diabétiques de différent type (type 1, 2 et gestationnel), consultants le centre de référence provincial de diabète (CRD), Kénitra-Maroc.MéthodesL'étude s'est déroulée s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 13 publications
(11 reference statements)
0
2
0
Order By: Relevance
“…In medical literature, the prevalence of hypomagnesemia in individuals living with T2DM is about 11–47% in almost all studies and case series [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ], which is higher than our prevalence. This prevalence is particularly higher in African countries, where the nutritional intake of magnesium is probably insufficient [ 26 , 27 , 28 ].…”
Section: Discussionmentioning
confidence: 50%
See 1 more Smart Citation
“…In medical literature, the prevalence of hypomagnesemia in individuals living with T2DM is about 11–47% in almost all studies and case series [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ], which is higher than our prevalence. This prevalence is particularly higher in African countries, where the nutritional intake of magnesium is probably insufficient [ 26 , 27 , 28 ].…”
Section: Discussionmentioning
confidence: 50%
“…In medical literature, the prevalence of hypomagnesemia in individuals living with T2DM is about 11–47% in almost all studies and case series [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ], which is higher than our prevalence. This prevalence is particularly higher in African countries, where the nutritional intake of magnesium is probably insufficient [ 26 , 27 , 28 ]. This large difference in these results is related to the differences in magnesium measurement and monitoring methods in heterogeneous populations with different population sizes.…”
Section: Discussionmentioning
confidence: 50%